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GWAS have emerged as popular tools for identifying genetic variants that are associated with disease risk. Standard analysis of a
case-control GWAS involves assessing the association between each individual genotyped SNP and disease risk. However, this approach
suffers from limited reproducibility and difficulties in detecting multi-SNP and epistatic effects. As an alternative analytical strategy, we
propose grouping SNPs together into SNP sets on the basis of proximity to genomic features such as genes or haplotype blocks, then
testing the joint effect of each SNP set. Testing of each SNP set proceeds via the logistic kernel-machine-based test, which is based on
a statistical framework that allows for flexible modeling of epistatic and nonlinear SNP effects. This flexibility and the ability to naturally
adjust for covariate effects are important features of our test that make it appealing in comparison to individual SNP tests and existing
multimarker tests. Using simulated data based on the International HapMap Project, we show that SNP-set testing can have improved
power over standard individual-SNP analysis under a wide range of settings. In particular, we find that our approach has higher power
than individual-SNP analysis when the median correlation between the disease-susceptibility variant and the genotyped SNPs is
moderate to high. When the correlation is low, both individual-SNP analysis and the SNP-set analysis tend to have low power. We apply
SNP-set analysis to analyze the Cancer Genetic Markers of Susceptibility (CGEMS) breast cancer GWAS discovery-phase data.Introduction
The identification of SNPs that are associated with risk
for developing complex disease is an important goal of
modern genetics studies. The hope is that such knowledge
can ultimately be used both for understanding the biolog-
ical mechanisms underlying these diseases and for gener-
ating individualized risk profiles that are useful in a public
health context. To this end, GWAS have emerged as a
popular tool for identifying common genetic variants for
complex disease. A standard case-control GWAS for identi-
fying SNPs associated with disease susceptibility involves
genotyping a large number of SNPs, on the order of
hundreds of thousands, in thousands of individuals with
the disease (cases) and thousands of healthy controls,
with the goal of identifying individual loci that are associ-
ated with the outcome. Such studies have been success-
fully used to identify SNPs associated with susceptability
to diseases such as breast cancer1,2 (MIM 114480), prostate
cancer3–5 (MIM 176807), and type 2 diabetes6–8 (MIM
125853).
A typical GWAS consists a discovery phase, in which an
initial set of promising susceptibility loci are identified,
followed by a validation stage, in which the SNPs identified
in the initial discovery phase are replicated in a separate
study cohort.9 The standard approach for analyzing
GWAS in the discovery phase involves individual-SNP
analysis. This mode of analysis often involves regressing
the phenotype onto each individual typed SNP and gener-
ating a parametric p value. The SNPs are then ranked on
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The Amesuch that all SNPs with a p value less than that threshold
will be pushed forward for validation. The threshold can
be based on reaching a multiple-comparison-adjusted sig-
nificance level or a level based on nonanalytical means.
Although the use of individual-SNP analysis has proven
useful in identifying many disease-susceptibility variants,
this mode of analysis may be limited in some settings
because of difficulty in reaching genome-wide significance.
More specifically, in order to control the overall type I error
rate, the level at which each test is conducted must be
adjusted. Because of the large number of considered
hypotheses, the threshold for genome-wide signficance
can be very extreme and difficult to attain: for a GWAS
examining the effects of 500,000 SNPs, each test is con-
ducted at the a ¼ 107 level, which is very stringent.
Additionally, individual-SNP analysis is often limited by
poor reproduceability; many of the highly ranked SNPs
in the discovery phase are false positives and cannot be
validated. This is largely due to the restricted power for
detecting SNPs with small effects that are truly associated
with the outcome. In particular, individual SNPs that are
genotyped on GWAS platforms often show only modest
effects. One explanation for this is that the true causal
SNP is rarely genotyped but there are typed SNPs that are
in linkage disequilibrium (LD) with the causal SNP. In
this case, when individual-SNP analysis is used, the typed
SNPs in LD with the causal SNP will each show only
moderate effects because each typed SNP serves as an
imperfect surrogate for the causal SNP. Thus, it could be
advantageous to consider the joint effect of multiple
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these markers are in LD with the causal SNP and could
capture the true effect more effectively than could indi-
vidual-SNP analysis. Finally, individual-SNP analysis
considers only the marginal effect of each SNP and there-
fore fails to accommodate epistatic effects. Epistatic interac-
tions between SNPs can contribute to disease susceptibility
such that individual SNPs may show little individual effect
but their interactions may have a much larger effect. Indi-
vidual-SNP analysis will not be able to detect such effects,
which, more generally, are difficult to find because of the
large number of potential interactions.11
As an alternative strategy for analysis, we propose
grouping SNPs together into SNP sets along the genome
and performing genome-wide tests for individual SNP
sets instead of individual SNPs. SNP-set-based analysis
borrows information from different but correlated SNPs
that are grouped on the basis of prior biological knowledge
and hence has the possibility of providing results with
improved reproducibility and increased power, especially
when individual-SNP effects are moderate, as well as
improved interpretability. This mode of analysis proceeds
via a two-step procedure. First, SNPs are assigned to SNP
sets on the basis of some meaningful biological criteria
(genomic features); e.g., genes. Then, tests for the associa-
tion between each genomic feature and a disease pheno-
type are performed with the use of a logistic kernel-
machine-based multilocus test, across the genome.
SNP-set analysis can prove advantageous over the
standard analysis of individual SNPs. By forming SNP sets
and testing each SNP set as a unit, we are reducing the
number of hypotheses being tested and thus relaxing the
stringent conditions for reaching genome-wide signifi-
cance. Grouping SNPs together properly, we will have
improved power in settings where SNPs are individually
only moderately significant. In particular, though any
single SNP may serve as a poor surrogate for an untyped
causal SNP, by considering multiple typed SNPs, we will
be better able to capture the true effect of the untyped
causal SNP. Furthermore, if there are multiple independent
causal SNPs, by considering their joint effects, we will have
power to detect their joint activity.
To test each SNP set within a case-control GWAS, we
propose a general semiparametric kernel-based testing
procedure that is tailored toward high-dimensional genetic
data. Specifically, this test will combine the logistic kernel-
machine testing approach of Liu et al.12 with the kernel
framework suggested by Kwee et al.13 As we will show, the
logistic kernel machine has appealing features for SNP-set
analyses. The testing framework is powerful and allows for
great flexibility in the functional relationship between the
SNPs in a SNP set and the outcome. Thus, the method can
easily account for complex SNP interactions and nonlinear
effects. Combined with the ability to seamlessly adjust for
covariate effects and the fast computational efficiency of
our method, this flexibility gives the logistic kernel-
machine-based test significant advantages over both
individual SNP tests and existing multimarker tests.930 The American Journal of Human Genetics 86, 929–942, June 11,Broadly speaking, our work advances the field in three
important ways. First, we develop SNP-set analysis as an
alternative to standard individual-SNP analysis and discuss
principled approaches for forming SNP sets based on
genomic features. Second, we develop a powerful statistical
modeling and testing framework for genetic effects, which
has a number of practical advantages over other multi-
marker tests: our approach is computationally efficient
and naturally accommodates covariate adjustment,
nonlinear effects, and epistasis. Third, we will demonstrate
through thorough numerical studies and data applications
that our approach can have substantially improved power
over standard individual-SNP testing and, by extension,
over the many multimarker tests that individual-SNP
testing tends to dominate.
The remainder of this article is organized as follows. In
the next section, we describe our proposed SNP-set analysis
framework, including how to form SNP sets and how to
subsequently test SNP sets. Then we will present simula-
tion results comparing our approach to individual-SNP
analysis and two existing multi-SNP tests. Finally, we will
apply logistic kernel-machine-based SNP-set analysis to
the Cancer Genetic Markers of Susceptibility (CGEMS)
breast cancer data from the discovery phase. We will
conclude with a brief discussion.Material and Methods
SNP-set-based analysis borrows information from different but
correlated SNPs that are grouped on the basis of prior biological
knowledge and hence provides results with improved reproduc-
ibility and increased power, especially when individual-SNP effects
are moderate. This mode of analysis proceeds via a two step proce-
dure. First, across the genome, SNPs are assigned to a SNP sets on the
basis of some meaningful biological criteria such as proximity to
genomic features—SNP sets of a single SNP are possible. If we
wished to perform genome-wide SNP-set analysis of a GWAS con-
ducted on the Illumina HumanHap500 array by grouping SNPs
on the basis of genes, we could generate approximately 18,000
SNP sets, each of which consisted of the SNPs within a single
gene. For example, the 14 genotyped SNPs within the ASAH1
(MIM 228000) gene could be assigned to a single SNP set and the
four genotyped SNPs within the NAT2 (MIM 612182) gene could
be assigned to another SNP set, and so on. After the groupings are
made, each of the 18,000 SNP sets is tested with the use of a multi-
locus test, and the genome-wide significance of the SNP set, e.g.,
each gene, is calculated. Although a number of tests have been
proposed,14,15 we consider an extension of the logistic kernel-
machine test, which was developed in the gene-expression-
profiling setting, which we tailor for analysis of GWAS. In this
section, we describe possible methods for grouping SNPs in
a genome-wide scan into SNP sets and then we present the logistic
kernel-machine test for evaluating the significance of each SNP set.
Forming SNP Sets
A key aspect of our proposed approach is the formation of mean-
ingful SNP sets. In principle, a SNP set may be formed via any
grouping of SNPs, and our testing approach is still valid in the
sense that the type I error rate will always be protected. However,2010
better groupings can be made on the basis of prior biological
knowledge and, if done properly, can lead to additional gains in
power. In particular, the key advantages of our approach may be
found in the ability to reduce the number of multiple compari-
sons, to harness correlation between SNPs, to measure the joint
effect of independent SNPs, and to make a direct inference on a
biologically meaningful genomic feature. Some natural ways of
forming SNP sets that can capitalize on these advantages include
grouping SNPs on the basis of genomic features. We describe
below some natural grouping structures.
A natural grouping strategy is to take all SNPs that are located in
or near a gene, a fundamental unit of the genome, and group
them to form a SNP set. In particular, one can take all SNPs
between the start and end of transcription as well as SNPs that
are upstream and downstream of the gene, in order to capture
regulatory regions, as a single SNP set. In grouping on the basis
of known genes, we can significantly reduce the number of
multiple comparisons. The SNPs on the Illumina HumanHap
500 array correspond to approximately 17,800 genes in contrast
to the original 530,000 SNPs. Because we take the entire gene
region, not just exonic regions, we expect to have many typed
SNPs that are correlated, and thus the logistic kernel-machine
test will have good power to detect a significant SNP-set effect.
We could also expect multiple SNPs within a gene to be associated
with disease risk, and this grouping structure would allow us to
detect this effect. Testing gene-based SNP sets also makes a direct
inference on the association between the gene and the case-
control status.
An extension of gene-based SNP-set analysis is to group SNPs on
the basis of whether they are located within a gene pathway from
the Kyoto Encyclopedia of Genes and Genomes (KEGG)16 or a
Gene Ontology Consortium functional category.17 Making infer-
ence on a pathway further reduces the number of multiple
comparisons and still allows inference on a biologically meaning-
ful unit. The logistic kernel-machine test will be able to harness
local LD to have power and will, additionally, be able to capture
true pathway effects when several SNPs in multiple genes are
related to the disease.
Although many variants associated with disease have been
identified within gene regions, many lie outside of the boundaries
of known genes (and hence pathways). To augment coverage of
the genome, a possible strategy would be to group SNPs within
evolutionarily conserved regions. Increased evolutionary conser-
vation of a genomic region is suggestive of increased importance
or functionality.18 Significance of such a SNP set would potentially
indicate that there is a genomic feature present that is related to
disease risk, even if the feature is not well understood.
Finally, approaches to forming SNP sets that can achieve full
coverage of the genome by placing all SNPs into SNP sets include
grouping SNPs via a moving window or via haplotype blocks. For
example, one could divide the genome into a fixed number of
adjacent regions, purely on the basis of length, and treat all
SNPs within a region as a SNP set. Alternatively, one could build
SNP sets based on haplotype blocks, such as through Haploview.19
Both approaches will still allow us to harness local correlation to
capture the effect of untyped SNPs.
An important limitation of employing a gene- or pathway-based
approach is the omission of intergenic regions. However, use of
additional grouping strategies, e.g., conserved regions, can
augment coverage, and using the moving window and haplotype
block can provide comprehensive coverage of the entire genome.
Although we wish to group SNPs that are near one another toThe Ameharness correlation, this does not allow us to capture multi-SNP
or epistatic effects among SNPs in separate SNP sets. Using gene-
pathway-based SNP sets could ameliorate this issue, because this
looks across individual continuous regions. Groupings based on
strategies beyond the ones that we have considered are also
possible.
As noted above, we emphasize that although well-formed SNP
sets can optimize the power and interpretability of our SNP-set
testing strategy, our logistic kernel-machine testing approach is
statistically valid irrespective of the grouping scheme. For illustra-
tion, we will focus on SNP sets formed on the basis of proximity to
each of 18,000 known genes.Genome-wide SNP-Set Testing
Although we propose our strategy as a genome-wide approach, we
will present the testing procedure by focusing on testing a single
SNP set.
In this paper, we assume that a population-based case-control
GWAS was conducted in which n independent subjects were
genotyped. To employ our SNP-set analysis approach, we first
group the SNPs into SNP sets across the genome. Then, for a given
SNP set containing p SNPs, let zi1, zi2, ., zip be genotype values for
the SNPs in the SNP set for the ith subject (i ¼ 1,.,n). The case-
control status for the ith subject is denoted by yi (yi ¼ 1 for cases,
and yi ¼ 0 for controls). We assume without loss of generality
that the SNPs are coded in a trinary fashion, with zij ¼ 0, 1, 2
corresponding to homozygotes for the major allele, heterozygotes,
and homozygotes for the minor allele, respectively. This corre-
sponds to the commonly employed additive model of allelic
effect, but we note that alternative models, such as the dominant
and recessive models, are also possible and can be tested within
our framework. We further assume that for each individual,
an additional set of m demographic, environmental, or other
confounding variables is collected. For the ith subject, we let
xi1, xi2, ., xim denote the values of the covariates that we would
like to adjust for. The goal of SNP-set analysis is then to test the
global null of whether any of the p SNPs are related to the outcome
while adjusting for the additional covariates.
In principle, many multilocus testing approaches could be used
for evaluating the significance of the SNPs in the SNP set, but to
harness correlation and accommodate complex relationships
between the SNPs and the outcome and epistatic effects, we
propose a new approach of testing the SNP set by modeling each
SNP set’s effect in a flexible fashion while adjusting for additional
covariate effects. At the same time, to overcome the issue of the
large number of degrees of freedom, our strategy will employ a
test that adaptively estimates the degrees of freedom by
accounting for correlation (LD) among the SNPs. Specifically, we
will choose to use the logistic kernel-machine regression modeling
framework and a corresponding score test.12
Logistic Kernel-Machine Model
In evaluating the significance of a SNP set, we need to employ a
strategy that allows us to model, and subsequently test, the effects
of multiple SNPs that have been grouped in a biologically mean-
ingful fashion. The kernel-machine framework has become very
popular for modeling high-dimensional biomedical data because
of its ability to allow for complex/nonlinear relationships between
the dependent and independent variables20,21 while adjusting for
covariate effects. We consider a logistic kernel-machine regression
model for the joint effect of the SNPs in the SNP set and the
additional covariates that we would like to adjust for. Under therican Journal of Human Genetics 86, 929–942, June 11, 2010 931












in which a0 is an intercept term and a1, ., am are regression coef-
ficients corresponding to the environmental and demographic
covariates. The SNPs, zi1, ., zip, influence yi through the general
function h($), which is an arbitrary function that that has a form
defined only by a positive, semidefinite kernel function K($, $).
Our primary aim is to adequately model the SNPs and evaluate
their effect, so h($) is the model component in which we have
primary interest because it fully determines the relationship
between genotypes of the SNPs in the SNP set and disease risk.
Leaving h($) only generally specified permits a modeling frame-
work that accommodates complex relationships between the
SNPs and risk as well as epistatic effects.
We omit the mathematical details, but when using the repre-
senter theorem,22 we note that h(zi1, zi2, ., zip) in Equation 1 is
equal to hi ¼ hðZiÞ ¼
Pn
i0¼1gi0KðZi,Zi0 Þ for some g1, ., gn. This
shows that h($) is fully defined by the kernel function K($, $).
Details on the mathematical relationships and estimation may
be found in Liu et al.12 and Cristianini et al.,20 but the key is
that by choosing different kernel functions, we can specify
different, possibly complex, bases and corresponding models.
For example, if we define K($, $) to be the linear kernel such that
KðZi,Zi0 Þ ¼
Pp
j¼1zijzi0 j then we are implicitly assuming the simple





¼ a0 þ a1xi1 þ.þ amxim þ b1zi1 þ b2zi2.þ bpzip,
in which bj is a regression coefficient corresponding to the j
th SNP.
To specify a more complicated model, we need only change our
choice of K($, $).
From the above, it is apparent that the choice of kernel changes
the underlying basis for the nonparametric function governing
the relationship between case-control status and the SNPs in the
SNP set. Essentially, K($, $) is a function that projects the genotype
data from the original space to another space and then h($) is
modeled linearly in this new space, such that if one considers h
on the original space, it can be highly nonlinear. More intuitively,
however, K(Zi, Zi0) can be viewed as a function that measures the
similarity between two individuals, the ith and i0th subject, on the
basis of the genotypes of the SNPs in the SNP set. Taking this
perspective, many choices for K are possible. Some specific kernel
functions that we can consider include the linear, identical-by-
state (IBS), and weighted IBS kernels.
The linear kernel is KðZi,Zi0 Þ ¼
Pp
j¼1zijzi0 j which is the usual
inner product between the covariate vectors for subject i and i0.
As described earlier, this kernel assumes a set of basis functions
that spans the original covariate space such that one is implying
a linear relationship between the logit of the probability of being
a case and the genotypes of the SNPs in the SNP set; i.e., the usual
multiple-logistic-regression model.
The Gaussian kernel is KðZi,Zi0 ; dÞ ¼ exp{
Pp
j¼1ðzij  zi0 jÞ
2=d}
and assumes the radial basis, which is difficult to characterize
with the use of an explicit set of basis functions. The class of
models generated by the Gaussian kernel can be very broad
and includes the linear model as a special case. Here, d is
a parameter that approximately controls curvature of the kernel
function, such that larger values of d correspond to smoother h
functions.932 The American Journal of Human Genetics 86, 929–942, June 11,The IBS kernel is KðZi,Zi0 Þ¼
Pp
j¼1 2Iðzij¼ zi0 jÞ þ Iðjzij  zi0 jj¼

1Þ =2pg . In genetics, a possible metric for evaluating distance
between individuals on the basis of genotype information is the
number of alleles with IBS sharing by a pair.15 As shown by
Kwee et al.,13 this may also be used as a valid kernel function.
The weighted IBS kernel is KðZi,Zi0 ; wÞ ¼
Pp
j¼1wj 2Iðzij ¼ zi0 jÞþ





and qj is the minor allele
frequency (MAF) for the jth SNP in the SNP set. The weighted IBS
kernel is an extension of the IBS kernel that up-weights for simi-
larity in rare alleles. The idea is that similarity in rare alleles is
more informative than similarity in common alleles.
The ability to model data by using the Gaussian and IBS kernels
is an advantage of using the kernel-machine framework, because
formulating an explicit set of basis functions can be difficult.
Alternative kernel functions, such as those discussed in Wei and
Schaid23 and in Mukhopadhyay et al.,24 are possible and can be
designed for specific data sets. To be a valid kernel function,
K($, $) needs to be positive and semidefinite and to satisfy the
conditions of Mercer’s theorem.20
Logistic Kernel-Machine Test
Here, our focus is on hypothesis testing, for which we need only to
estimate a under the null hypothesis that h(Zi) ¼ 0. Therefore, we
omit the technical details on estimating the genetic effect, h(Z),
from the SNP set and refer the reader to Liu et al.12
The above modeling framework leads naturally to a powerful
test for association between the SNPs in the SNP set and the
case-control status. Note that the probability that the ith subject
is a case depends on the SNPs only through the function h(Zi).
Thus, in order to test whether there is a true SNP-set effect, we
can consider the null hypothesis that
H0 : hðzÞ ¼ 0 (Equation 2)
against the general alternative. To test this hypothesis, Liu et al.12
exploit the connection between the kernel-machine framework
and generalized linear mixed models (GLMM). Specifically, letting
K be the n 3 n matrix with the (i, i0)th element equal to K(Zi, Zi0), it
is straightforward to see that h¼K g, in which h¼ [h1, ., hn]0. We
can treat h as a subject-specific random effect, then via the GLMM
connection, h follows an arbitrary distribution F with a mean of
zero and a variance of tK. Note that t indexes the effect of the
SNPs in the SNP set such that
H0 : hðZÞ ¼ 05H0 : t ¼ 0:
Thus, we need only to test whether the indexing parameter t is
significantly different than zero. This can proceed via the variance-








in which logit bp0i ¼ ba0 þ ba1xi1 þ ba2xi2 þ/þ bamxim. Because this
is a score test, ba0 and baj are estimated under the null model, which
does not contain h, so we can use the standard estimate from the
logistic-regression model without the genotypes. To compute a
p value for significance, we can compare Q to a scaled c2 distribu-
tion with scale parameter k and degrees of freedom n. Details on
calculating k and n are found in Appendix A.
The adaptive estimation of the degrees of freedom, n, constitutes
a key advantage of the logistic kernel-machine test. In particular, if
the R2 between the SNPs in the SNP set increases, then n decreases
such that if all the SNPs are perfectly correlated, n/1. It follows
that for a given h($), higher correlation is likely to lead to higher2010
power, suggesting that the logistic kernel-machine test improves
the power for SNP-set testing by harnessing the correlation
between SNPs and adaptively estimating n.
In general, it can be difficult to identify a priori whether it is the
minor allele or the major allele that is associated with increased
disease risk and, equivalently, whether the minor allele is protective
or deleterious. The logistic kernel-machine test is not affected by
the directionality of effect, and its power is robust to whether the
minor alleles of the causal SNP are protective or deleterious (or
a combination of both in settings with multiple causal variants).
The testing framework considered here has similarities to those
of Schaid et al.,10 Mukhopadhyay et al.,24 and Wessel and
Schork,15 which we describe below in that all three approaches
are based on genetic distances among subjects. However, the
kernel framework allows for improved flexibility in the functional
relationship.
Existing Multi-SNP Tests
Although other multi-SNP tests could be used for evaluating the
significance of each SNP set, the kernel machine has advantages
over each of these. Here, we briefly discuss some alternative tests
that fall into several different categories.
The first class of multi-SNP test encompasses the multimarker
methods that are based on individual-SNP analysis. In particular,
a common approach for evaluation the significance of a set of
markers is to apply individual-SNP analysis by testing the indi-
vidual significance of each SNP, using the most significant p value
as the p value for the set of loci, and then correcting for having
done multiple tests via Monte Carlo methods26 or by estimating
the effective number of tests.27–29 Alternatively, the test statistics
from each of the individual tests can be combined.30 However,
such tests still rely strongly on individual-SNP analysis, and
when the individual SNPs are not in high LD with the causal
variant, they may have low power, because they do not borrow
information across SNPs that are frequently correlated. Further-
more, they cannot accommodate complex genetic effects and
interactions. Our simulations will verify that the logistic kernel-
machine test often has improved power over this class of test.
Omnibus tests for multiple SNPs or haplotypes via multivariate
regression10,31 allow for simultaneous analysis of all SNPs, but
studies have shown that such methods often offer little benefit
over methods based on individual-SNP analysis,32,33 because
they are based on a large number of degrees of freedom. To reduce
the degrees of freedom, a set of multimarker tests that compare
pairwise genetic similarity with pairwise trait similarity were
proposed by Schaid et al.,14 Wessel and Schork,15 and Mukhopad-
hyay et al.24 All three approaches are attractive; however, as noted
by Mukhopadyay et al., an important limitation of Schaid et al.’s
approach is that it assumes all variants have the same direction
of effect, i.e., all the minor alleles for each SNP increase risk or
all minor alleles decrease risk. Although the methods of Wessel
and Schork and Mukhopadhyay et al. are robust to directionality,
both evaluate significance via computationally expensive permu-
tation which may be impractical for some GWAS settings. None of
the three similarity based methods allow for easy covariate adjust-
ment. The logistic kernel-machine test also considers pairwise
similarity and shares the attractive nonparametric SNP effects
model, but in addition to using a computationally efficient score
test and being robust to directionality, the logistic kernel-machine
model naturally incorporates covariate effects, an important
feature. Beyond adjusting for confounders and population struc-
ture, it is often necessary to adjust for highly significant SNPs in
GWAS to distinguish between settings where a particular signifi-The Amecant marker is the causal SNP (or a SNP in high LD with the causal
SNP), versus settings where additional independent markers that
are associated with disease are present. A third similarity based
approach by Tzeng and Zhang34 can be seen as a special case of
the more general logistic kernel-machine test that focuses exclu-
sively on haplotype similarity. The need to phase sample haplo-
types from genotype data incurs additional computational
expense and variability—particularly for larger SNP sets.
A final class of multimarker tests consists of methods that
leverage explicit population-genetics models to pinpoint the
causal locus. Many involve reconstructing the sample phylogeny
to guide the analysis and infer the causal mutation.35,36 If the
population-genetics model assumed is realistic and correct, such
problem-specific methods should have high power. However, it
is difficult to validate the assumed models, and most procedures
are computationally intensive, such that in real applications the
models need to be simplified. Once again, these models usually
fail to allow for covariate adjustment. Computational efficiency
and ease of covariate adjustment give a practical advantage to
the logistic kernel-machine regression test.Simulations
To evaluate the performance of our SNP-set analysis approach, we
study the logistic kernel-machine test in the genetics framework
by considering its empirical performance under a variety of
settings. For simplicity of implementation, all causal SNPs in our
simulations are assumed to increase disease risk, but it is important
to note that none of the methods that we consider are affected by
the direction of effect.
Simulations Based on the ASAH1 Gene
We first investigate the size and power of the kernel-machine
testing framework under a setting in which the SNP set is gener-
ated on the basis of the LD structure of a single gene, which will
allow us to better understand under which settings our SNP-set
analysis approach is most advantageous. We considered the
ASAH1, NAT2, and FGFR2 (MIM 176943) genes, but for clarity,
we present only the simulation configurations and the results
based on the ASAH1 gene. The simulations and results from use
of the NAT2 and FGFR2 genes were qualitatively similar.
ASAH1, acid ceramidase 1, is a 28.5-kb-long gene with 86
HapMap SNPs and is located at 8p21.3-p22. Expression is associ-
ated with prostate cancer,37 and mutations in the gene are known
to be associated with Farber disease38 (MIM 228000). We based our
gene-specific simulations on the LD structure of the ASAH1 gene
and used HAPGEN39 and the CEU sample (CEPH [Utah residents
with ancestry from northern and western Europe]) of the Interna-
tional HapMap Project40 to generate SNP genotype data at each of
the 86 loci.41 A total of 14 out of 86 SNPs are genotyped with the
use of the Illumina HumanHap500 array. These will be the ‘‘typed’’
SNPs that we use for our simulated analysis.
We first conducted simulations to verify that the logistic kernel-
machine test properly controls the type I error rate. To investigate
the empirical size of our test, we conducted simulations in which
we generated n/2 cases and n/2 controls under the null logistic
model in which disease risk does not depend on the genotype:
logit P

yi ¼ 1 jXi

¼ a0 þ a0Xi, (Equation 4)
in which Xi is a vector of covariates. We considered n¼ 1000, 2000
and also considered the use of the linear, IBS, and weighted IBS
kernels. For each choice of n and kernel function, we generated
5000 data sets by using HAPGEN. To ensure that our simulationsrican Journal of Human Genetics 86, 929–942, June 11, 2010 933
are realistic, although our simulations generated all 86 HapMap
SNPs, we apply our testing approach only to the 14 typed SNPs.
Specifically, we group the 14 SNPs as a SNP set based on the
ASAH1 gene and then we apply the logistic kernel-machine test
to compute a p value evaluating the effect of the SNPs in the SNP
set while adjusting for covariates in X. For comparison, we also
analyzed the 14 typed SNPs as we would have done under an indi-
vidual-SNP analysis: we tested the significance of each of the 14
SNPs individually, while again adjusting for covariates in X, and
then adjusted the individual p values via a modified Bonferroni
correction in which the effective number of tests was computed
via two approaches. First, we used the method of Moskvina
et al.29 Second, we estimated the effective number of tests as the
number of principal components necessary to account for 99% of
the variability.42 The two approaches were approximately concor-
dant. The smallest p value, corrected for the effective number of
tests, was taken as the p value for the entire SNP set. The size for indi-
vidual-SNP analysis testing was again the proportion of p values less
than a ¼ 0.05.
To compute the empirical power for a SNP set, we generated data




yi ¼ 1 jXi

¼ a0 þ a0Xi þ bczci , (Equation 5)
in which zi
c is the genotype for the ‘‘causal’’ SNP, bc is the log
genetic odds ratio (OR) for the causal SNP, and Xi are a vector of
additional covariates. Note that under each simulation configura-
tion we allow only a single causal SNP. Each of the 86 HapMap
SNPs was set to be the ‘‘causal’’ SNP in turn. Setting bc¼ 0.2, which
corresponds to a genetic OR of 1.22, we again considered sample
sizes n ¼ 1000, 2000. For each choice of n, and for each of the
86 causal SNPs, we generated 2000 data sets. We again applied
our testing approach to each data set by grouping the 14 typed
SNPs and computing a p value for the significance of the SNP set,
while adjusting for covariates in X, via the logistic kernel-machine
test under a linear kernel. We emphasize that only the 14 typed
SNPs were used so the causal SNP is unobserved under most
configurations. For each configuration, we then computed the test
power as the proportion of p values less than the a level ¼ 0.05.
This was compared with the power based on the individual-SNP
analysis with the modified Bonferroni correction approach
described above.
Simulations Based on Randomly Sampled Genes
We also evaluate the power of our approach under settings in
which the LD structure of the simulated SNP sets varied across a
wide range of possible genes. Specifically, we generated 20,000
SNP sets by using HAPGEN, in which each SNP set is based on a
real gene on chromosome 10. This allows for 670 possible SNP
sets. Within each SNP set, we randomly selected one HapMap
SNP to be the causal SNP and again generated n/2 cases and n/2
controls based on a model given by Equation 5, with bc again fixed
at 0.2 (OR ¼ 1.22). Again treating the SNPs on the Illumina
HumanHap 500K array as the typed SNPs, we tested the signifi-
cance of the SNP set by using the logistic kernel-machine test
under a linear kernel. We also apply the individual-SNP analysis
testing procedure described above. Thus, for both our method
and the competing individual-SNP analysis test, we computed
20,000 p values for significance.
Comparisons with Alternative Multi-SNP Tests
As discussed previously, in principle, any multi-SNP test can be
used to test the significance of a SNP set. However, the kernel-934 The American Journal of Human Genetics 86, 929–942, June 11,machine test is advantageous in that it adaptively finds the degrees
of freedom of the test statistic in order to account for LD between
genotyped markers, can permit complex relationships between
the SNPs and the outcome, naturally allows for covariate adjust-
ment, and is computationally efficient because no permutation
is required. To provide additional empirical results, we compare
the logistic kernel-machine test to the similarity-based testing
approach of Mukhopadhyay et al.24 and the approach of Wessel
and Schork,15 which has been found to perform well relative to
other multi-SNP tests.23 We assessed the power under five models
and the test size under two additional models. For each of the five
models examining power, 500 simulations were conducted, and
1000 simulations were conducted under the two models exam-
ining the test size. For all seven models, we assumed sample sizes
of 500 cases and 500 controls, 1000 permutations were used to
compute the p values for the methods of Wessel and Schork and
Mukhopadhyay et al., and power and size were computed as the
proportion of p values less than 0.05.
We first compare the power of the methods under four alternative
models using SNP sets based on the ASAH1 gene. Under model 1, the
data sets were simulated under the alternative logistic model based
on Equation 5, in which the causal variant was fixed to be rs3810
(the third in the SNP set), one of the 14 typed SNPs, with bc again
fixed at 0.2 (OR ¼ 1.22). Model 2 was similar to model 1, except
that we change the causal SNP to be rs7825389 (the 69th SNP), an un-
typed SNP. Model 3 was again similar to the earlier models, except
that we allow for two causal variants, rs10105871 and rs7825389,
which are the 63rd and 69th SNPs in the ASAH1 SNP set, respectively.
Both SNPs are in the same LD block, and rs10105871 is typed
whereas rs7825389 is untyped. The effect size for both causal SNPs
was set at 0.2. Model 4 is identical to model 3, but here we have
two untyped causal SNPs that are in different LD blocks, rs4377998
and rs7825389, which are the 43rd and 69th SNPs, respectively.
Under model 5, we compared the power under the setting
considered by Mukhopadhyay et al., in which ten independent
markers in Hardy-Weinberg equilibirium with MAF ¼ 0.05 are
simulated. Two of the ten markers were causal, with relative risks
of 1.25 under an additive model, and all ten markers were consid-
ered to be genotyped. No additional covariates are present.
We compare the type I error rate control of the logistic kernel-
machine test and the approaches by Wessel and Schork and
Mukhopadhyay et al. Specifically, under model 6, we simulated
null data sets based on Equation 2 and the ASAH1 gene. We
applied both approaches to each of the data sets to estimate
p values for the significance of the SNPs in the SNP set, and the
size for each approach was estimated as the proportion of p values
less than the 0.05 significance level. Model 7 is similar to model 6,
but we generate an additional demographic covariate that is corre-
lated with rs3810 (r ¼ 0.065), the third SNP in the SNP set.
CGEMS Breast Cancer Data
To demonstrate the applicability and power of our approach on
real data, we apply SNP-set analysis to real GWAS data and contrast
our results with those found under individual-SNP analysis.
The Cancer Genetic Markers of Susceptibility (CGEMS) breast
cancer study1 was conducted to identify individual SNPs associ-
ated with breast cancer risk. To this end, in the discovery phase,
1145 cases with invasive breast cancer and 1142 controls were
genotyped at 528,173 loci with the use of an Illumina Human-
Hap500 array. All subjects were postmenopausal women of Euro-
pean ancestry recruited from the Nurses Health Study. The results
of the top SNPs from the discovery phase are given in Table 1. In2010
Table 1. Top Results from the Discovery Phase of the CGEMS
Breast Cancer GWAS
SNP Chromosome Gene p Value
rs10510126 10 2.0 3 106
rs12505080 4 8.0 3 106
rs17157903 7 RELN 9.0 3 106
rs1219648 10 FGFR2 1.2 3 105
rs7696175 4 TLR1, TLR6 1.4 3 105
rs2420946 10 FGFR2 1.5 3 105
rs2107349 7 AZGP1, AZGP1P2 1.7 3 105
rs6497337 16 SYT17 2.0 3 105
rs1250255 2 FN1 3.4 3 105
rs10804287 2 3.8 3 105
Table 2. Empirical Type I Error Rates at a ¼ 0.05 for the Logistic
Kernel-Machine Test and Individual-SNP Analysis when Applied to









1000 0.049 0.052 0.046 0.055
2000 0.048 0.047 0.053 0.052the initial validation study, the top six SNPs as well as two others
in the FGFR2 gene were genotyped in an independent set of 1776
cases and 2072 controls. A SNP within FGFR2 was validated and
found to be associated with risk of breast cancer. Note that the
SNPs in FGFR2 were not the top-ranked variants and that the vari-
ants within FGFR2 do not reach genome-wide significance with
the use of either the Bonferroni correction or a false discovery
rate (FDR) correction in the initial scan.
To evaluate the performance of SNP-set analysis with the logistic
kernel-machine-based test, we applied it to reanalysis of the
CGEMS breast cancer data. Specifically, we formed SNP sets by
grouping SNPs that lie within the same gene. To ensure that
SNPs with possible gene-regulatory roles were also included in
the SNP sets, we grouped all SNPs from 20 kb upstream of a gene
to 20 kb downstream of a gene. Using these criteria, we were
able to assemble a total of 17,774 SNP sets that consisted of
310,219 unique typed SNPs. We tested each of the gene-based
SNP sets by using the logistic kernel-machine test under the linear
kernel, the IBS kernel, and the weighted IBS kernel. SNPs were
coded in the additive mode, and we adjusted for parametric effects
of age group, whether the individual had hormone therapy, and
the first four principal components of genetic variation to control
for population stratification.43Results
Empirical Size and Power Based on the ASAH1 Gene
The size results for the logistic kernel-machine test and
individual-SNP analysis are presented in Table 2. On the
basis of our simulations, the logistic kernel-machine test
has correct size for the kernels and has sample sizes cor-
rected, and therefore, our overall strategy of logistic
kernel-machine-based SNP-set analysis protects the type I
error rate. Individual-SNP analysis with modified Bonfer-
roni correction also has correct size. As expected, the
average effective number of tests over the 5000 replicates
was stable irrespective of sample size: 8.22 for n ¼ 1000
and 8.23 for n ¼ 2000.
We present the empirical power results for simulation
based on the ASAH1 gene in the top panel of Figure 1.
The power for each testing approach and sample size isThe Ameshown for each of the 86 HapMap SNPs acting as the causal
SNP. On the basis of Figure 1, we can see that both methods
have power when the causal SNP is in moderate or high LD
with the 14 typed SNPs. In these settings, the power for our
logistic kernel-machine SNP-set analysis approach tends to
dominate individual-SNP analysis for both considered
sample sizes, suggesting that our testing approach is an
attractive alternative or auxiliary method to individual-
SNP analysis. For settings in which the causal SNP was
not in LD with the typed SNPs, the power was approxi-
mately at the type I error rate, as we would expect.
For the purpose of clarifying the optimal conditions for
our testing approach, Figure 2 shows the power for each
testing approach, and sample size is again presented, but
here the causal SNPs on the horizontal axis are ordered
by the median R2 of the causal SNP with the 14 typed
SNPs. The median R2 between the causal SNP and the 14
typed SNPs is plotted in the bottom panel. It is evident
from the plots that the power for both testing approaches
grows as a function of the median R2 between the causal
SNP and the typed SNPs. On the right side of the plot
where the median R2 is moderate to high, the kernel-
machine-based testing tends to have dramatically
improved power over individual-SNP analysis even when
the causal SNP is genotyped. When the median R2 is low,
neither approach has much power. We emphasize that
we consider the median R2 and not the maximum R2 and
note that the power for the kernel-machine test is not
necessarily the highest for situations in which the causal
SNP is typed.
We repeated the size and power calculations based on
the ASAH1 gene for SNPs coded in a dominant model
(results not shown). We also repeated power calculations
for SNP sets with LD structure based on the FGFR2 and
NAT2 genes. The size was again correct, and power plots
are qualitatively similar.
The empirical studies show that logistic kernel-machine-
based SNP-set analysis protects the type I error rate. Further-
more, except for the causal SNPs in low LD with the
genotyped SNPs (for which neither method has any power
beyond the type I error rate and hence any differences in
power are random), the kernel-machine-based SNP-set
analysis has greater power than individual-SNP analysis.
Empirical Power Based on Randomly Sampled Genes
To summarize our results, we divide the 20,000 simula-
tions into three groups on the basis of p, the number ofrican Journal of Human Genetics 86, 929–942, June 11, 2010 935
Figure 1. Empirical Power for SNP Sets Based on ASAH1 and LD Plot for the 86 SNPs in the ASAH1 Gene Based on the CEU Sample
from the International HapMap Project
The typed SNPs are denoted with a triangle, and the bottom panel shows the LD structure of the SNPs in the ASAH1 gene.typed SNPs within the SNP set. Essentially, we computed
power after binning the 20,000 simulations on the basis
of the SNP-set size and then the median R2 between the
causal SNP and the typed SNPs. More specifically, we split
the simulations into groups in which p % 10, in which
10< p % 20, and in which 20< p. Then we further divided
each of the three groups into subgroups by sorting the
simulated SNP sets on the basis of the median R2 between
the causal SNP and the typed SNPs and then splitting the
group into 50 evenly sized subgroups. Within each sub-
group, we estimated the power as the proportion of
p values less than a ¼ 0.05. For each of the groups, we
plot the kernel-density smoothed power against the
median R2 for the subgroups in Figure 3. We need to divide
the SNP sets on the basis of the number of SNPs because936 The American Journal of Human Genetics 86, 929–942, June 11,distantly located SNPs are uncorrelated, such that the
median R2 decreases with increased numbers of typed
SNPs.
The plots verify the earlier result that we found: the
power increases as a function of the median R2 between
the causal SNP and the typed SNPs. If the causal SNP is
uncorrelated with most typed SNPs, then we have little
power to detect the SNP-set effect, but if there is any power,
then the kernel-machine-based SNP-set analysis method
again tends to have higher power than individual-SNP
analysis. Both the overall power and the relative power
of our approach to individual-SNP analysis increases as
the number of typed SNPs increases. This again indicates
that our approach may be a better alternative to indi-
vidual-SNP analysis.2010
Figure 2. Empirical Power for SNP Sets Based
on ASAH1
The SNPs on the x axis are sorted by median R2
with the 14 typed SNPs, which are shown in
the bottom plot.Multi-SNP Test Comparison Results
The results comparing the power and type I error rates of
the logistic kernel-machine test and the Wessel and Schork
approach are presented in Figure 4. As expected, if the
number of independent causal SNPs is increased, the
power for both approaches increases. Across the first four
models, which compare the empirical power under prac-
tical settings based on the ASAH1 gene, the logistic
kernel-machine test tends to have higher power than
both the Wessel and Schork method, with a gain of approx-
imately 12%–18%, and the approach of Mukhopadhyay
et al., which improves little over the type I error rate. Under
model 5, which assumes common MAF and no LD among
typed SNPs within a gene and two causal SNPs that are gen-
otyped, the logistic kernel-machine test and Mukhopad-
hyay et al.’s approach perform similarly, and both have
considerably higher power than the Wessel and Schork
method. Overall, these results suggest that the logistic
kernel-machine test has optimal power relative to other
multi-SNP tests across different patterns of LD. More inter-
esting are the simulations comparing the type I error rate.
When the demographic and environmental covariates
were simulated independently of the genotype informa-
tion, the size for all three tests is correct. However, when
we set correlation between the covariates, which is associ-
ated with the outcome and the genotypes as being modest
(0.065), failing to account for the covariates when using
the Wessel and Schork and Mukhopadhyay et al. methods
might possibly lead to an apparently inflated type I errorThe American Journal of Hrate of 25% and 10%, respectively. This
illustrates the importance of evaluating
the significance of SNP sets in the presence
of possible confounders.
Additional power simulations based on
the ASAH1 gene, in which as many as four
causal SNPs were used, did not yield qualita-
tively different results, in that the logistic
kernel-machine test tended to have higher
power. Because this is unlikely to be a real-
istic situation, given the rarity of risk-associ-
ated common variants and the relatively
small regions, these results are omitted.
We note that Mukhopadhyay et al.’s
approach has power similar to that of the
logistic kernel-machine test under model 5.
This is a setting that favors their approach.
In particular, the method of Mukhopadhyay
et al. is based on an ANOVA model that
assumes that the effects of the modeled
SNPs are constant and that the residualcorrelation among kernel-similarity scores is the same across
all different pairs of cases or controls considered. Conse-
quently, the method of Mukhopadhyay et al. will have
excellent power when these modeling assumptions hold
but may lose power when such assumptions are violated,
such as under models 1–4. The logistic kernel-machine test
does not make the same assumptions as the method of
Mukhopadhyay et al.; for example, the effect sizes of
the modeled SNPs and MAFs are allowed to vary in our
approach.
Given that the power of the logistic kernel machine
tends to be comparable or higher, and given the difficulties
posed by failure to adjust for demographic and environ-
mental covariates and the additional computation cost
incurred by permutation, the logistic kernel-machine test
appears to be an attractive approach for testing the signif-
icance of SNP sets.
CGEMS Breast Cancer Data Analysis Results
The results of our reanalysis may be found in Table 3.
Using our approach and the linear kernel, we see that the
SNP set formed of genetic variants close to the FGFR2
gene is now the most highly ranked SNP set, with a p value
equal to 7.69 3 107 and an FDR q-value equal to 0.01.
At that signficance level, it also reaches genome-wide
significance if we apply a Bonferroni correction (a ¼
0.05/17, 774 ¼ 2.8 3 106) or if we control the FDR.
With the use of a Bonferroni correction, FGFR2 again rea-
ches genome-wide significance if we use the IBS kernel,uman Genetics 86, 929–942, June 11, 2010 937
Figure 3. Smoothed Empirical Power
Curves as a Function of Median R2
between the Causal SNP and the Typed
SNP for SNP Sets Based on a Range of
Genesand if we control the FDR at 5%, it reaches significance
with the weighted IBS kernel as well.Discussion
In this article, we propose logistic kernel-machine-based
SNP-set analysis as an approach for the analysis of case-
control GWAS. Our approach employs prior biological
knowledge to group multiple SNPs that are located near938 The American Journal of Human Genetics 86, 929–942, June 11, 2010genomic features into SNP sets and
then tested as a single unit. Specifi-
cally, we choose to model the SNPs in
the SNP set by using a flexible, semi-
parametric modeling framework that
is based on kernel machines, and we
choose to test the effects of the SNP
set via a powerful variance-compo-
nents test. We illustrate our approach
by using both data simulated from
the International HapMap Project40
and data from the CGEMS breast
cancer GWAS of Hunter et al.,1 and
we show that our approach is an
attractive alternative or auxiliary
approach to individual-SNP analysis.
The logic behind our analysis
strategy is that we can borrow infor-
mation between different SNPs to
improve the power to detect true
effects. Thus, the choice of grouping
can influence the power of our
approach. We focused on grouping
SNPs on the basis of their proximity
to a known gene and noted that this
allowed us to reduce multiple com-
parisons and to harness local LD
structure in order to improve the
power for capturing untyped SNPs.
Using genes as the genomic features
of interest allows us to map approxi-
mately 310K SNPs to 18K SNP sets.
However, it may be that the causal
SNP lies far from a known gene, in
which case groupings based on genes
(and, by extension, pathways) will
fail to capture the effect of interest.
To augment coverage of gene-desert
regions, we can group SNPs on the
basis of additional genomic features,such as evolutionarily conserved regions. Such groupings
again allow us to harness local correlation. The moving-
window approach will be useful for capturing all geno-
typed SNPs, but direct interpretation of SNP-set analysis
results are more difficult, though this may not be impor-
tant. Groupings via haplotype blocks are attractive because
they make explicit use of the LD information. Use of
haplotype blocks will allow for comprehensive coverage
of the entire genome and will remove the need to explicitly
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Figure 4. Comparison of the Power and Type I Error of the
Logistic Kernel-Machine Test, the Wessel and Schork Method,
and Mukhopadhyay et al.’s Approach
Abbreviations are as follows: K, logistic kernel-machine test; W,
Wessel and Schork method; M, Mukhopadhyay et al.’s approach.
Power and size estimates are based on 500 and 1000 simulations,
respectively. The blue line shows the expected type I error rate.
Table 3. Top Results from the Logistic Kernel-Machine-Based
SNP-Set Analysis of the CGEMS Breast Cancer Study Data
Linear IBS Weighted IBS
Gene p Value q-Value p Value q-Value p Value q-Value
FGFR2 7.69 3 107 0.01 2.53 3 106 0.03 1.35 3 105 0.05
CNGA3 5.59 3 106 0.05 4.65 3 106 0.03 3.25 3 106 0.02
TBK1 1.30 3 105 0.07 3.28 3 106 0.03 5.48 3 106 0.02
VWA3B 1.53 3 105 0.07 7.84 3 106 0.03 3.99 3 106 0.02
PTCD3 5.50 3 105 0.20 9.02 3 106 0.03 3.78 3 106 0.02
XPOT 6.60 3 105 0.20 3.48 3 105 0.09 4.91 3 105 0.11
VAPB 9.79 3 105 0.22 4.51 3 105 0.10 8.11 3 105 0.14
SHC3 1.01 3 104 0.22 3.77 3 104 0.34 1.61 3 103 0.46
SFTPB 1.78 3 104 0.31 1.38 3 104 0.27 7.62 3 105 0.14
SPATA7 1.90 3 104 0.31 1.76 3 104 0.28 1.39 3 104 0.22Beyond harnessing local LD structure to boost power,
another important feature of our approach is the ability
to model the joint effect of multiple, independent, causal
signals as well as possible epistatic effects. Practically, how-
ever, finding a SNP-set formation strategy that optimizes
for this can be difficult. Using a gene or moving-window
strategy can certainly capture multi-SNP and epistatic
effects among SNPs that are located close to one another
on the genome, but identification of such signals among
SNPs that are distantly placed will not be possible. A poten-
tial strategy is to use existing prior biological knowledge. In
particular, if multiple SNPs are expected to affect the
disease risk, it is not unreasonable to expect them to lie
within genes in the same pathway or in genes with similar
function; hence, forming SNP sets on the basis of pathways
can potentially capture such effects. Unfortunately, a
systematic approach for identifying such grouping struc-
tures at the genome-wide level is not obvious. To avoid
bias in our testing procedure, any grouping strategy must
be made without consideration of the case-control status
of the subjects in the data set. Thus, groupings must be
made with the use of information from external sources,
prior studies, or unsupervised statistical methods. As
such, SNP-set formation strategies will improve with
advances in our knowledge of the genome and genomic
structures.
Although we focused our power simulations on the
linear kernel, our simulation results nevertheless suggest
that our approach is as powerful as individual-SNP analysis
and that our approach can often have improved power
over both the individual-SNP analysis strategy and other
multi-SNP testing methods. In particular, we are able to
show that when the causal SNP is correlated with multiple
typed SNPs, our approach has higher power than indi-
vidual-SNP analysis. In settings where the causal SNP is
not correlated with multiple typed SNPs, simulations
show that neither individual-SNP analysis nor ourThe Ameapproach will be able to detect an effect. Recall that,
here, the term individual-SNP analysis refers to correcting
the smallest individual p value for the SNPs in the SNP
set for multiple comparisons and using the adjusted
p value as the p value for the entire SNP set. The minimum
uncorrected p value for a SNP set may be smaller than the p
value from the logistic kernel-machine test but would lead
to a significantly inflated type I error rate. Under several
settings, we found that the kernel-machine test tended to
have improved power over competing multi-SNP tests
while naturally allowing for covariate adjustment to
protect the type I error rate when confounders are present.
We noted earlier that the linear kernel corresponds to
the usual simple logistic model whereas the IBS and
weighted IBS are kernels tailored specifically to genetic
data and the quadratic kernel is potentially useful for
modeling epistatic effects. In fact, when epistatic effects
are present, the IBS kernel can allow for dramatically
improved power over the linear kernel. The ability to allow
for complex relationships between the SNPs by specifying
just a single distance metric is an attractive feature of our
approach. In practice, however, one needs to choose
a kernel a priori. Although our simulations demonstrated
that the size of our test is correct irrespective of the kernel
used, the power will be influenced by the choice of kernel.
The best way of choosing a kernel to use is unclear, because
methods using the data to be tested are likely to overfit and
simulations may reflect the process under which the data
were simulated. Our experience in simulations and real-
data applications suggests using the linear kernel for
testing SNP sets in which no epistatic effects are antici-
pated (such SNP sets based on short regions) and using
the IBS kernel otherwise. Our experience is that there is a
small loss in power for use of the IBS kernel when the
true effect is linear but that there is potentially a consider-
able loss in power when the true effect is complex and/or
epistatic and the linear kernel is applied. Future researchrican Journal of Human Genetics 86, 929–942, June 11, 2010 939
is necessary to study the power obtained when using other
types of kernels.
Our numerical results lead us to recommend our kernel-
machine approach for performing multi-SNP analysis
across a range of realistic settings. We have shown that it
has more power compared to existing popular approaches.
It also has the ability to adjust for covariates. This is partic-
ularly attractive because one usually needs to control for
possible population stratification and additional con-
founders in association studies. As noted by Mukhopad-
hyay et al.,24 the performance of individual multi-SNP tests
can depend on a range of factors, including the number of
causal SNPs, effect size, and LD structure. Future research is
needed for more comprehensive comparisons; e.g., in
other settings and with other multi-SNP methods.
For a SNP set that is significantly associated with disease
susceptibility, it is of great interest to subsequently perform
fine mapping and identify the individual causal variants.
One strategy that can be used is to apply a variable-selec-
tion procedure to select the ‘‘most important’’ SNPs. For
instance, one could use a LASSO penalized logistic regres-
sion44 to regress the case-control status on the 14 SNPs in
the ASAH1 SNP set. LASSO penalized logistic regression
will cause some of the regression coefficients to be esti-
mated as exactly zero, dropping the corresponding vari-
ables from the model. Such a strategy has been used by
others.45–47 However, existing variable-selection literature
does not allow for selection of features within the logistic
kernel-machine regression framework in the presence of
SNP-SNP interactions. The optimal strategy for quantifying
the contributions of individual SNPs remains an area of
considerable interest.
In addition to being able to account for complex SNP
effects and to adjust for covariates, the key advantage of
the logistic kernel-machine test is the ability to adaptively
estimate the degrees of freedom. As discussed earlier, when
the genotyped SNPs are highly correlated, the degrees of
freedom of the test remain approximately constant. As a
result, the strength of our method can increase as progress
in genotyping technology allows for denser screens.Appendix A
Approximating the Null Distribution of the Score
Statistic for the Logistic Kernel-Machine Test
The score statistic Q defined by Equation 3 tests the null
hypothesis that H0:t ¼ 0 and is based on the variance-
components tests developed by Zhang and Lin25 and
Lin48 and adapted by Liu et al.12 Note that this is a
boundary case, so the null distribution for Q follows a
complex mixture of c2. This can be approximated via
the Satterthwaite method49 as a scaled chi-square distribu-
tion, kc2n, in which the scale parameter, k, and the degrees
of freedom, n, are calculated via moment matching.
Specifically, for D0 ¼ diagðbp0ið1 bp0iÞÞ and P0 ¼ D0 –
D0X(X
0D0X)
–1X0D0, we define mQ ¼ tr(P0K)/2, Itt ¼940 The American Journal of Human Genetics 86, 929–942, June 11,tr(KP0KP0)/2, Its ¼ tr(P0KP0)/2, Iss ¼ tr(P0P00)/2, and
~Itt ¼ Itt  I2ts=Iss. Then k can be estimated as
k ¼ ~Itt=ð2mQÞ and we can calculate the p value for signifi-
cance by comparing Q/k to a chi-square distribution of n
degrees of freedom, c2n, in which n ¼ 2m2Q=~Itt. The original
derivation of our score test can be found in Lin,48 in
which the link function in Equation 2 of Lin is assumed
to be the logit and the design matrix (Z) is set to be K1/2.
Our score statistic, Q, in Equation 4 is identical to the
first term of the score statistic, U, from Equation 8 of Lin
(as _D ¼ 1 and D–1W ¼ D because the logit link is a
canonical link).Acknowledgments
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